富满微(300671) - 2021 Q3 - 季度财报

Revenue and Profit Growth - Revenue for Q3 2021 reached ¥331,491,218.13, an increase of 26.44% year-over-year, and total revenue for the year-to-date is ¥1,182,365,338.37, up 130.51% compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2021 was ¥168,563,621.95, a significant increase of 355.24% year-over-year, with year-to-date net profit at ¥484,730,525.55, up 687.85%[3] - Basic earnings per share for Q3 2021 was ¥0.82, reflecting a 256.52% increase year-over-year, while year-to-date earnings per share reached ¥2.37, up 478.05%[3] - The company reported a significant increase in sales revenue from 465,996,952.01 to 979,017,910.21, representing a growth of 109.0%[40] - Net profit for the period was ¥480,182,448.91, reflecting a significant growth of 691.17% year-over-year[13] - The total comprehensive income attributable to the parent company's owners is 484,642,468.64, compared to 61,155,435.55, an increase of 694.5%[36] Assets and Liabilities - Total assets as of September 30, 2021, amounted to ¥2,194,777,292.75, representing a 32.83% increase from the end of the previous year[3] - The total assets increased to CNY 2,194,777,292.75 as of September 30, 2021, compared to CNY 1,652,292,547.90 at the end of 2020[26] - The total liabilities as of September 30, 2021, were CNY 697,385,974.06, up from CNY 612,544,468.21 at the end of 2020[26] - The total liabilities increased to $612.54 million, compared to $678.11 million, with a change of $65.57 million[53] Cash Flow and Investments - The company's cash flow from operating activities for the year-to-date was ¥121,975,529.22, an increase of 273.14% compared to the same period last year[3] - The cash flow from investment activities increased by 168.13% to ¥691,796,720.98, primarily due to the maturity of bank wealth management products[13] - The net cash flow from investing activities was -$141.44 million, compared to -$173.71 million in the previous period[46] - The total cash and cash equivalents at the end of the period amounted to $120.49 million, down from $227.63 million in the previous period[46] Research and Development - Research and development expenses surged to ¥115,253,343.43, marking a 221.67% increase due to higher investment in new product development[10] - Research and development expenses increased to 115,253,343.43 from 35,829,249.13, marking a rise of 221.5%[31] Other Financial Metrics - The weighted average return on equity for Q3 2021 was 12.71%, an increase of 8.93% year-over-year, with a year-to-date return on equity of 47.41%, up 39.48%[3] - The company received government subsidies amounting to ¥17,937,565.19, an increase of 86.80% compared to the previous period[10] - The company's tax expenses rose significantly by 866.37% to ¥45,547,157.83, reflecting the impact of substantial profit growth[13] - The company reported a decrease in accounts receivable to CNY 344,755,966.92 as of September 30, 2021, from CNY 447,961,977.37 at the end of 2020[20]